Germany’s Cambrium bags €8M to shift towards a bio-based economy with molecular design tech
Berlin-based Cambrium, a synthetic biology startup, announced on Tuesday, October 31, that it has secured €8M in a seed round of funding led by Essential Capital, with participation from SNR, Valor Equity Partners, and HOF Capital.